Cargando…

Recommendations for Interpreting and Reporting Silent Carrier and Disease-Modifying Variants in SMA Testing Workflows

Genetic testing for SMA diagnosis, newborn screening, and carrier screening has become a significant public health interest worldwide, driven largely by the development of novel and effective molecular therapies for the treatment of spinal muscular atrophy (SMA) and the corresponding updates to test...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milligan, John N., Blasco-Pérez, Laura, Costa-Roger, Mar, Codina-Solà, Marta, Tizzano, Eduardo F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498682/ https://www.ncbi.nlm.nih.gov/pubmed/36140824 http://dx.doi.org/10.3390/genes13091657

Ejemplares similares

The clinical landscape for SMA in a new therapeutic era
por: Talbot, K, et al.
Publicado: (2017)

The Importance of Digging into the Genetics of SMN Genes in the Therapeutic Scenario of Spinal Muscular Atrophy
por: Costa-Roger, Mar, et al.
Publicado: (2021)

Beyond copy number: A new, rapid, and versatile method for sequencing the entire SMN2 gene in SMA patients
por: Blasco‐Pérez, Laura, et al.
Publicado: (2021)

Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain
por: López-Bastida, Julio, et al.
Publicado: (2017)

Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows
por: Sobahy, Turki M., et al.
Publicado: (2022)

The Carrier Frequency of Two SMN1 Genes in Parents of Symptomatic Children with SMA and the Significance of SMN1 Exon 8 in Carriers
por: Davidson, Joanne E, et al.
Publicado: (2023)

Deep Molecular Characterization of Milder Spinal Muscular Atrophy Patients Carrying the c.859G>C Variant in SMN2
por: Blasco-Pérez, Laura, et al.
Publicado: (2022)

Performance analysis of graphene modified asphalt and pavement performance of SMA mixture
por: Yong, Peng, et al.
Publicado: (2022)

Evaluating the efficacy of three carrier screening workflows designed to identify at‐risk carrier couples
por: Arjunan, Aishwarya, et al.
Publicado: (2021)

The effectiveness of styrene-maleic acid (SMA) copolymers for solubilisation of integral membrane proteins from SMA-accessible and SMA-resistant membranes
por: Swainsbury, David J.K., et al.
Publicado: (2017)

Recommendations for the collection and use of multiplexed functional data for clinical variant interpretation
por: Gelman, Hannah, et al.
Publicado: (2019)

Recommendations for clinical interpretation of variants found in non-coding regions of the genome
por: Ellingford, Jamie M., et al.
Publicado: (2022)

Calcium channels SMA
por: Williams, Ruth
Publicado: (2007)

Alambres musculares (SMA) /
por: Hernández Ramírez, Edgar
Publicado: (2001)

An enhanced workflow for variant interpretation in UniProtKB/Swiss-Prot improves consistency and reuse in ClinVar
por: Famiglietti, M L, et al.
Publicado: (2019)

Non silente
por: Pérez Maseda, Eduardo, 1953-

“I have SMA, SMA doesn’t have me”: a qualitative snapshot into the challenges, successes, and quality of life of adolescents and young adults with SMA
por: Mazzella, Allison, et al.
Publicado: (2021)

Markers of long term silent carriers of Streptococcus equi ssp. equi in horses
por: Pringle, John, et al.
Publicado: (2020)

Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!
por: Bartlett, Amy, et al.
Publicado: (2018)

MedSMA℞T Adventures in PharmaCity Game: Youth Experiences and Recommendation for Use in Opioid Safety Education
por: Abraham, Olufunmilola, et al.
Publicado: (2023)

Silent sinus syndrome (First Case Report, Saudi Arabia with recommendation)
por: AlSaloom, Nouf S., et al.
Publicado: (2020)

View of building SMA18
por: Valeriane Duvivier
Publicado: (2001)

View of building SMA18
por: Valeriane Duvivier
Publicado: (2001)

View of building SMA18
por: Valeriane Duvivier
Publicado: (2001)

New Directions for SMA Therapy
por: Messina, Sonia
Publicado: (2018)

An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA members
por: Belter, Lisa, et al.
Publicado: (2018)

Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA Cohort
por: Jones, Cynthia C., et al.
Publicado: (2020)

BIOMEX: an interactive workflow for (single cell) omics data interpretation and visualization
por: Taverna, Federico, et al.
Publicado: (2020)

A workflow reproducibility scale for automatic validation of biological interpretation results
por: Suetake, Hirotaka, et al.
Publicado: (2023)

A Bioconductor workflow for processing, evaluating, and interpreting expression proteomics data
por: Hutchings, Charlotte, et al.
Publicado: (2023)

Reclassification of DMD Duplications as Benign: Recommendations for Cautious Interpretation of Variants Identified in Prenatal Screening
por: He, Wenbin, et al.
Publicado: (2022)

Most synonymous allelic variants in HIV tat are not silent
por: Giacoletto, Christopher J., et al.
Publicado: (2023)

Case Report: Progression of a Silent Corticotroph Tumor to an Aggressive Secreting Corticotroph Tumor, Treated by Temozolomide. Changes in the Clinic, the Pathology, and the β-Catenin and α-SMA Expression
por: Demarchi, Gianina, et al.
Publicado: (2022)

Influence of Embedding SMA Fibres and SMA Fibre Surface Modification on the Mechanical Performance of BFRP Composite Laminates
por: Liu, Yanfei, et al.
Publicado: (2018)

How do SMA-linked mutations of SMN1 lead to structural/functional deficiency of the SMA protein?
por: Li, Wei
Publicado: (2017)

Plastin 3 Expression Does Not Modify Spinal Muscular Atrophy Severity in the ∆7 SMA Mouse
por: McGovern, Vicki L., et al.
Publicado: (2015)

NFL is a marker of treatment response in children with SMA treated with nusinersen
por: Olsson, Bob, et al.
Publicado: (2019)

CarrierSeq: a sequence analysis workflow for low-input nanopore sequencing
por: Mojarro, Angel, et al.
Publicado: (2018)

SMA building at Point 1.8.
por: Serge Dailler
Publicado: (1999)

SMA building at Point 1.8.
por: Serge Dailler
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_bjbdlek0afc98qak78cmv1jku0